- $17.70m
- $72.40m
- $2.45m
Annual balance sheet for PAVmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 6.25 | 17.5 | 78 | 42.7 | 22.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 0.2 | 0.017 | 0.061 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6.55 | 18.9 | 82.6 | 43.9 | 24.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | 1.58 | 5.49 | 6.05 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 7.24 | 19.8 | 87 | 54 | 33.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.9 | 20.3 | 7.56 | 41.2 | 54.2 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.1 | 17.9 | 25.3 | 63.7 | 87 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | -3.82 | 1.9 | 61.7 | -9.68 | -53.8 |
| Total Liabilities & Shareholders' Equity | 7.24 | 19.8 | 87 | 54 | 33.1 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |